Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

NCT02581137 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

NIH

Sponsor class

Conditions

Erythroplakia
Hyperplasia
Oral Cavity Carcinoma
Oral Leukoplakia

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Metformin Hydrochloride

Sponsor

National Cancer Institute (NCI)